Science News

Having radiotherapy once a day for six and a half weeks or twice a day for three weeks -- when combined with chemotherapy -- is equally good at treating small cell lung cancer that hasn't spread.

The experimental "smart-bomb" drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer, according to results from a first-in-human clinical trial.

The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug's target, according to...

Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research.

Hispanic white and non-Hispanic black cancer patients between ages 15 and 29 may be more likely than same-aged white patients to die of their disease, according to a new study. The finding is partially but not wholly exp...

Tiny plastic particles from our washing products end up in seas and are ingested by marine organisms. The UK is about to decide whether to ban the beads

If you're like me, you've spent countless hours scrolling through Netflix, trying to find the perfect show to watch. According to one estimate, adults make as many as 35,000 decisions in a day. Most -- like picking a sho...

A new drug that harnesses the immune system to attack tumors is highly effective against advanced bladder cancer, according to the results of an international clinical trial.

(University of Pittsburgh Schools of the Health Sciences) An existing cancer immunotherapy drug reduces tumor size in some types of rare connective tissue cancers, called sarcomas, report researchers at the University of...